Advertisement

Topics

Chiesi Group Company Profile

06:48 EST 11th December 2016 | BioPortfolio

The Company, founded in Parma in 1935, is today an international reality in the pharmaceutical market. With global operations consisting of 21 direct affiliates, 3 manufacturing sites, and 3 research centres, the Group has over 2,700 employees, of whom 300 are involved in research and development activities.

Chiesi’s technologies and products are available in over 50 countries through a strategic alliances network of international pharmaceutical groups developed both on a global and local scale. Group turnover reached 565 million Euros in 2005. Historically, the continuous development of the Company has been based on strategic planning for innovation, internationalisation, socially compatible economical values, and use of effective organizational structures.

Chiesi's formula for success is based on a peculiar approach that allows to combine factors often thought of as opposites in the pharmaceutical industry – such as research and ethics, technology and humanity, commitment to results and concern for individuals, reliability and empathy – while encouraging innovation at all levels. The final goal is the creation of value through innovation.

Location

Chiesi Farmaceutici S.p.A.Via Palermo, 26/A,
Parma
43100
Italy

Contact

Phone: 39 0521 2791
Fax: 39 0521 774468
Email: info@chiesigroup.com


News Articles [750 Associated News Articles listed on BioPortfolio]

Chiesi submits MAA in Europe for triple combo inhaler

Italian family-owned drugmaker Chiesi Farmaceutici has submitted a marketing authorization application…

Chiesi’s Cham Herath confident that triple combo can lead the next wave of COPD treatments

Cham Herath, the medical director at Italian drugmaker Chiesi Farmaceutici, knew that news of his company’s…

Chiesi buys asthma company, pitting it against Novartis

Novartis has moved into Phase 3 testing of its oral asthma drug fevipiprant, which works in a similar manner to Chiesi's newly acquired asthma candidate. 

Chiesi’s triple combo inhaler shows benefit in COPD

Chiesi has unveiled results of a late-stage study showing the superior efficacy of its triple combination inhaler for chronic obstructive pulmonary disease (COPD) compared with standard dual therapy.

Chiesi Takes Aim At Next-Generation Eosinophilic Asthma Therapy

Chiesi may be coming late to the development of eosinophilic asthma therapies, but there are certain advantages associated with acquisition...   

Chiesi Completes the Acquisition of Three Hospital Products -- Kengreal(R), Cleviprex(R) and Argatroban(TM) for Injection

PARMA, ITALY--(Marketwired - June 22, 2016) - Chiesi USA, Inc. and Chiesi Farmaceutici S.p.A., Chiesi USA's parent company, announced today that the companies have finalized the acquisition of multina...

Chiesi completes acquisition of cardiovascular medications from The Medicines Company

The Medicines Company completed its divestiture of three cardiovascular medications to Chiesi USA, Inc. on June 21, one month after the companies agreed to the deal.

#news #biotech Chiesi buys Atopix for clinical-stage asthma pipeline

// Chiesi buys Atopix for clinical-stage asthma pipeline nick.paul.taylor Mon, 11/21/2016 – 06:53 from Feed http://ift.tt/2gcOz6f Cet article #news #biotech Chiesi buys Atopix for clinical-stage...

PubMed Articles [2407 Associated PubMed Articles listed on BioPortfolio]

Improvement of the Marginal Reflex Distance-1 in Blepharoptosis Surgeries.

The aim of this study was to predict the improvement of the marginal reflex distance (MRD1) in each blepharoptosis surgery.In PubMed and Scopus, the search terms 1. (blepharoptosis) AND 2. (surgery) A...

In-Group Versus Out-Group Source Memory.

A common finding in the source monitoring literature is that greater similarity impairs source discriminability. Experiments traditionally manipulate similarity overtly by describing or showing source...

Principles of Psychodynamic Group Psychotherapy.

This paper describes different historical developments of the application of psychodynamic treatments within groups and shows some factors reflecting significant influences on the outcome of group psy...

Histopathologic comparison of dexmedetomidine's and thiopental's cerebral protective effects on focal cerebral ischemia in rats.

This study was designed to investigate whether dexmedetomidine and thiopental have cerebral protective effects after focal cerebral ischemia in rats. Thirty male Sprague Dawley rats were randomly assi...

Protective effects of thoracic epidural anesthesia on hypoxia-induced acute lung injury in rabbits.

The mechanism underlying the effect of thoracic epidural anesthesia (TEA) on hypoxia-induced acute lung injury (ALI) is currently unknown. In the present study, a rabbit acute lung injury model was es...

Clinical Trials [2583 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

The purpose of this trial is to verify if the test treatment BDP 250 mcg/salbutamol 100 mcg HFA pMDI fixed combination is non-inferior to BDP 250 mcg/salbutamol 100 mcg pMDI fixed combina...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Companies [1534 Associated Companies listed on BioPortfolio]

Chiesi Group

The Company, founded in Parma in 1935, is today an international reality in the pharmaceutical market. With global operations consisting of 21 direct affiliates, 3 manufacturing sites, and 3 research ...

Chiesi Farmaceutici S.p.A.

Chiesi Pharmaceuticals, which started up in 1935 as a small family company is today an international company in the pharmaceutical sector and operates in all 5 continents with 24 direct branches, 3 ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "Chiesi Group" on BioPortfolio

We have published hundreds of Chiesi Group news stories on BioPortfolio along with dozens of Chiesi Group Clinical Trials and PubMed Articles about Chiesi Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chiesi Group Companies in our database. You can also find out about relevant Chiesi Group Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Bioethics
Bioethics is the study of controversial ethics brought about by advances in biology and medicine. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, and philo...


Corporate Database Quicklinks



Searches Linking to this Company Record